GSK Revenue and Competitors
Estimated Revenue & Valuation
- GSK's estimated annual revenue is currently $33.3B per year.
- GSK's estimated revenue per employee is $346,635
- GSK's total funding is $25.5M.
- GSK's current valuation is $114.4B. (January 2022)
Employee Data
- GSK has 96153 Employees.
- GSK grew their employee count by 1% last year.
GSK's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Executive Assistant to President | Reveal Email/Phone |
2 | Field VP | Reveal Email/Phone |
3 | Executive Assistant to the VP & Communications Coordinator | Reveal Email/Phone |
4 | Executive Assistant to VP Human Ressources Vaccines | Reveal Email/Phone |
5 | Executive Assistant to VP | Reveal Email/Phone |
6 | VP, Head Late & Life Cycle Development Portfolio | Reveal Email/Phone |
7 | Head Automated Systems R&D | Reveal Email/Phone |
8 | Head Global Quality for Suppliers & Incoming Materials | Reveal Email/Phone |
9 | Head, Integrated Systems & Support | Reveal Email/Phone |
10 | Head Global Submission Production, Regulatory Platforms & Systems | Reveal Email/Phone |
GSK Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $32820M | 83449 | 7% | N/A | $182.4B |
#2 | $69340M | 107310 | 4% | N/A | $308.4B |
#3 | $512.7M | 1459 | N/A | N/A | N/A |
#4 | $16.1M | 80 | 1% | N/A | N/A |
#5 | $42310M | 169995 | 5% | N/A | $226.6B |
What Is GSK?
GlaxoSmithKline - one of the world\'s leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer.
keywords:Biotechnology, Pharmaceuticals, Health and Wellness, Heathcare
$25.5M
Total Funding
96153
Number of Employees
$33.3B
Revenue (est)
1%
Employee Growth %
$114.4B
Valuation
N/A
Accelerator
GSK News
New Jersey, USA,- The research study presented here is a very detailed and meticulous description of almost all major aspects of the global Parki.
An industrial brawl could be brewing at GlaxoSmithKline. Hundreds of GSK employees in the U.K. have voted to strike against a derisory pay raise offer...
GlaxoSmithKline plc Investor Science Event Getting ahead of anaemia due to chronic kidney disease ASN Kidney Week 2021 7 November 2021 17:00 GMT Mick Readey: Good afternoon and good evening, welcome to GSK's Investor Science Event: Getting ahead of anaemia from chronic kidney disease, for i ...
GLAXOSMITHKLINE Q3 2021 Results Wednesday, 27 October 2021 Nick Stone (Head of Investor Relations): Good morning, good af ternoon. As you've just heard, I am Nick Stone, Head of Investor Relations at GSK. It's my pleasure to welcome you to our third quarter 2021 conference call and webcast fo ...
Issued: London UK ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc ("GSK"), with Pfizer Inc. and Shionogi Limited as shareholders, today presented positive interim data from the CARISEL (Cabotegravir and Rilpivirine Implementation Study in European Locat ...